ATE109005T1 - Pharmazeutische zubereitung für die reifung von prothymozythen. - Google Patents

Pharmazeutische zubereitung für die reifung von prothymozythen.

Info

Publication number
ATE109005T1
ATE109005T1 AT91810023T AT91810023T ATE109005T1 AT E109005 T1 ATE109005 T1 AT E109005T1 AT 91810023 T AT91810023 T AT 91810023T AT 91810023 T AT91810023 T AT 91810023T AT E109005 T1 ATE109005 T1 AT E109005T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
prothymocytes
maturation
ige
prothymocyte
Prior art date
Application number
AT91810023T
Other languages
English (en)
Inventor
Patrice Prof Dr Debre
Mohammad Djavad Dr Mossalayi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of ATE109005T1 publication Critical patent/ATE109005T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91810023T 1990-01-24 1991-01-15 Pharmazeutische zubereitung für die reifung von prothymozythen. ATE109005T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909001625A GB9001625D0 (en) 1990-01-24 1990-01-24 A pharmaceutical preparation for maturation of prothymocytes

Publications (1)

Publication Number Publication Date
ATE109005T1 true ATE109005T1 (de) 1994-08-15

Family

ID=10669826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91810023T ATE109005T1 (de) 1990-01-24 1991-01-15 Pharmazeutische zubereitung für die reifung von prothymozythen.

Country Status (11)

Country Link
US (1) US5236706A (de)
EP (1) EP0447353B1 (de)
JP (1) JPH05117163A (de)
AT (1) ATE109005T1 (de)
AU (1) AU643245B2 (de)
CA (1) CA2034737A1 (de)
DE (1) DE69103053T2 (de)
ES (1) ES2057833T3 (de)
GB (1) GB9001625D0 (de)
IE (1) IE910229A1 (de)
PT (1) PT96540A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
GB9601042D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Medical use
EP0797450A4 (de) * 1994-12-01 2000-02-02 New England Deaconess Hospital In vitro t-lymphopoiese system
US6410714B1 (en) * 1999-03-24 2002-06-25 Heska Corporation Canine low affinity IgE receptor (CD23) nucleic acid molecules and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808611A (en) * 1986-07-30 1989-02-28 Immunex Corporation Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
US5135851A (en) * 1990-05-08 1992-08-04 Kajander E Olavi Culture and detection method for sterile-filterable autonomously replicating biological particles

Also Published As

Publication number Publication date
CA2034737A1 (en) 1991-07-25
IE910229A1 (en) 1991-07-31
DE69103053T2 (de) 1994-12-01
PT96540A (pt) 1991-10-31
ES2057833T3 (es) 1994-10-16
GB9001625D0 (en) 1990-03-21
EP0447353A1 (de) 1991-09-18
EP0447353B1 (de) 1994-07-27
AU6934791A (en) 1991-07-25
AU643245B2 (en) 1993-11-11
JPH05117163A (ja) 1993-05-14
US5236706A (en) 1993-08-17
DE69103053D1 (de) 1994-09-01

Similar Documents

Publication Publication Date Title
ATE84215T1 (de) Arzneizubereitung zur oralen anwendung.
DE69019716D1 (de) Medizinisches Gerät zur Laserbehandlung.
DE3886046D1 (de) Sich selbst stumpf machende nadeleinheit sowie diese aufweisende vorrichtung.
DE3783068D1 (de) Medizinische vorrichtung.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
DE69202739D1 (de) Gemischtes Alkylmethylsiloxane zur Hautpflege.
DE3876417D1 (de) Einmalfilter.
DE3677565D1 (de) Medizinische vorrichtung.
FI874660A7 (fi) Aine hammasjäljennöksiä varten.
DE3876288D1 (de) Desinfektions- und sterilisierungsmittel.
DE58906881D1 (de) Gerät zur Zahnbehandlung.
DE3862490D1 (de) Mittel zur insekten- und milbenabwehr.
DE3763507D1 (de) Patientenlagerungstisch.
ATE109005T1 (de) Pharmazeutische zubereitung für die reifung von prothymozythen.
DE58904845D1 (de) Zahnaerztliches saughandstueck.
DE3763140D1 (de) Patientenlagerungstisch.
DE3783401D1 (de) Medizinische roehre und herstellungsverfahren.
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
DK191089D0 (da) Biologisk aktive forbindelser
FI871393A7 (fi) Potilaan vuodealusta.
ES2094757T3 (es) Un factor megacariocitopoyetico.
DE68922150D1 (de) Vorrichtung zur elektrochemischen Behandlung.
DE3785305D1 (de) Medizinisches geraet.
DE69003722D1 (de) Zahnärztliches Handstück.
KR900011306U (ko) 화염에 의한 살충, 살균 및 제초기

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee